<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Philadelphia (Ph) chromosome, or t(9;22), is the hallmark of <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>It results in juxtaposition of the 5' part of the BCR gene on chromosome 22 to the 3' part of the ABL1 gene (previously ABL) on chromosome 9 </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0005481'>CML</z:mp> is clinically characterized by three distinct phases: <z:hpo ids='HP_0011010'>chronic</z:hpo>, accelerated, and <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast phase</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">Blast crisis</z:e> is characterized by the rapid expansion of a population of differentiation arrested blast cells (myeloid or lymphoid cells population), with secondary chromosomal abnormalities present </plain></SENT>
<SENT sid="4" pm="."><plain>We report a case of myeloid <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> of <z:mp ids='MP_0005481'>CML</z:mp> resistant to <z:chebi fb="0" ids="31690">imatinib mesylate</z:chebi> and chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>By use of cytogenetic, fluorescence in situ hybridization, and comparative genomic hybridization methods, we identified a cluster of BCR-ABL amplification on inverted duplication of the Ph chromosome with t(3;21)(q26;q22) and increased genomic levels of the RUNX1 gene (previously AML1) </plain></SENT>
<SENT sid="6" pm="."><plain>The t(3;21)(q26;q22) is a recurrent chromosomal abnormality in some cases of <z:mp ids='MP_0005481'>CML</z:mp> <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast phase</z:e> and in treatment-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Amplification or copy number increase of RUNX1 has been reported in childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Our study indicated that the progenitor of <z:mp ids='MP_0005481'>CML</z:mp> was BCR-ABL dependent through the amplification of Ph chromosome as a mechanism of resistance to <z:chebi fb="0" ids="45783">imatinib</z:chebi> therapy </plain></SENT>
<SENT sid="9" pm="."><plain>The coexistence of BCR-ABL and t(3;21)(q26;q22) with RUNX1 rearrangement might play a pivotal role in the <z:mp ids='MP_0005481'>CML</z:mp> blast transformation </plain></SENT>
</text></document>